2 reports

R& D Progress Research and Development Brief Company reported that the drug candidate has demonstrated superior activity in tumors where PD-## monotherapy or PD-##/ LAG-## monoclonal antibody combo has shown activity.

  • Immunotherapy
  • Monoclonal Antibody
  • Research And Development
  • Therapy
  • MacroGenics, Inc.
  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. - Research and Development Overview

R& D Progress Research and Development Brief Mechanism of Action Paclitaxel is under development for the treatment of tumors.

  • Pharmaceutical
  • Research And Development
  • China
  • Company Operations
  • Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.